Intracellular and extracelluar cyclic GMP in the brain and the hippocampus.
Autores de CIPF
Grupos de Investigación
Abstract
Cyclic Guanosine-Monophosphate (cGMP) is implicated as second messenger in a plethora of pathways and its effects are executed mainly by cGMP-dependent protein kinases (PKG). It is involved in both peripheral (cardiovascular regulation, intestinal secretion, phototransduction, etc.) and brain (hippocampal synaptic plasticity, neuroinflammation, cognitive function, etc.) processes. Stimulation of hippocampal cGMP signaling have been proved to be beneficial in animal models of aging, Alzheimer's disease or hepatic encephalopathy, restoring different cognitive functions such as passive avoidance, object recognition or spatial memory. However, even when some inhibitors of cGMP-degrading enzymes (PDEs) are already used against peripheral pathologies, their utility as neurological treatments is still under clinical investigation. Additionally, it has been demonstrated a list of cGMP roles as not second but first messenger. The role of extracellular cGMP has been specially studied in hippocampal function and cognitive impairment in animal models and it has emerged as an important modulator of neuroinflammation-mediated cognitive alterations and hippocampal synaptic plasticity malfunction. Specifically, it has been demonstrated that extracellular cGMP decreases hippocampal IL-1ß levels restoring membrane expression of glutamate receptors in the hippocampus and cognitive function in hyperammonemic rats. The mechanisms implicated are still unclear and might involve complex interactions between hippocampal neurons, astrocytes and microglia. Membrane targets for extracellular cGMP are still poorly understood and must be addressed in future studies.
Datos de la publicación
- ISSN/ISSNe:
- 0083-6729,
- Tipo:
- Article
- Páginas:
- 247-288
- PubMed:
- 35180929
Vitamins and Hormones ELSEVIER ACADEMIC PRESS INC
Citas Recibidas en Web of Science: 2
Documentos
- No hay documentos
Filiaciones
Keywords
- Astrocyte, Cognitive impairment, Extracellular cGMP, Hippocampus, Microglia, Neuroinflammation, PKG, Synaptic plasticity, cGMP
Proyectos asociados
Identification and modelling of molecular and cellular events of the inmune response associated to the appearence of minimal hepatic encephalopaty in cirrhotic patients
Investigador Principal: VICENTE FELIPO ORTS
FUNDACION RAMON ARECES . 2019
Mecanismos moleculares de las alteraciones neurológicas (cognitivas y motoras) en hiperamonemia y encefalopatía hepática. Implicaciones terapéuticas.
Investigador Principal: VICENTE FELIPO ORTS
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2021
Molecular mechanisms of the neurological (cognitive and motor) alterations in hyperammonemia and hepatic encephalopathy. Therapeutic implications.
Investigador Principal: VICENTE FELIPO ORTS
CONSELLERIA DE EDUCACION . 2022